MONTPELLIER, France--(BUSINESS WIRE)--SeqOne Genomics, contiguous announced that Michael Blum, Ph.D. is joining the institution to pb its probe and improvement department. He is tasked with driving SeqOne’s R&D strategy notably successful the country of uncommon diseases and oncology done the usage of instrumentality learning and information science.
Michael started his vocation arsenic a biostatistician and bioinformatician astatine the CNRS wherever helium developed bundle solutions that enabled analyzable genomic information investigation for biologists and clinicians. He past acceptable up the Grenoble Data Institute, a cross-disciplinary probe group, to survey however integer exertion and information could beryllium harnessed to payment subject and society. In 2019, helium joined Owkin where, for the past 3 years, helium has developed AI-based solutions to optimize objective trials.
At SeqOne, Michael volition pb technological probe and the improvement of caller genomic investigation solutions to amended the objective mentation and diagnosis of crab and hereditary diseases. Michael Blum has co-authored implicit 50 technological publications, galore of which are the effect of planetary collaborations successful the fields of colonisation genomics and genomic medicine.
Michael holds an engineering grade from Grenoble INP, a PhD successful applied mathematics, and completed a post-doctorate successful bioinformatics astatine the University of Michigan.
“SeqOne has developed an awesome acceptable of ground-breaking technologies built connected hard science”, said Michael Blum. “We stock the aforesaid imaginativeness that aims to beforehand personalised medicine by creating a choky enactment betwixt exertion and medicine. I americium honoured to beryllium portion of SeqOne’s absorption team, starring probe initiatives to make ever much effectual diagnostic solutions that volition accelerate entree to personalized medicine for each patients.”
“Our full squad is delighted that Michael is joining us”, commented Nicolas Philippe, CEO and co-founder of SeqOne Genomics. “His immense expertise successful information subject and biology represents an bonzer plus for the improvement of our planetary programme to make objective genomic investigation solutions. His committedness to advancing and spreading cognition volition assistance widen our enactment among the cardinal players successful personalized genomic medicine.”
About SeqOne Genomics
English (US)